Capitalizing on Opportunities to Drive Impact in Commercial Operations

Throughout the first half of 2022, we’ve continued to face historic, unprecedented challenges related to the ongoing global pandemic. Life sciences enterprises, and essentially all industries, are grappling with decisions large and small. Priorities for Commercial, Market Access and Medical Affairs organizations in the life sciences industry continue to shift as teams work feverishly to evolve virtual and digital channels to engage with customers, and to sharpen Advanced Analytics. Developing capabilities and skills in new ways of working continue in the forefront of strategic priorities, along with increasing challenges in securing and retaining the right talent. Challenges related to vaccinations, variants, and decisions on returning to the office have seemed like a roller coaster.  

Every day, our member companies reach out to TGaS Advisors for guidance in navigating this uncharted territory, and we proactively support more than 2,000 individuals across 300 partner companies. The findings in this Advisory Brief are based on our work with these companies and relate to key themes that emerged during our 2022 Spring Virtual Client Summit.

Complete the form below to access the full brief

We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.